ArticleNeurology2013
Incidence and prevalence of treated epilepsy among poor health and low-income Americans.
Article in Neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.
- Pooled it
- Incident Epilepsy Among US Medicare Beneficiaries, 2019: Differences by Age, Sex, and Race/Ethnicity.Neurology · 2024Article
- Excess prevalence of preexisting chronic conditions in older adults with incident epilepsy.Epilepsia · 2024Article
- Disparities in Epilepsy Diagnosis and Management in High-Income Countries: A Review of the Literature.Neurology. Clinical practice · 2024Review
- Prevalence, demographic and spatial distribution of treated epilepsy in France in 2020: a study based on the French national health data system.Journal of neurology · 2024Article
- The Frequency and Precipitating Factors for Breakthrough Seizures in Children with Epilepsy.Journal of epilepsy research · 2023Article
- The burden of epilepsy and unmet need in people with focal seizures.Brain and behavior · 2022Review
- Association between social deprivation and incidence of first seizures and epilepsy: A prospective population-based cohort.Epilepsia · 2022Article
- Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures.Neuropsychiatric disease and treatment · 2022Article
- Inconsistent Medicaid Coverage is Associated with Negative Health Events for People with Epilepsy.Journal of health care for the poor and underserved · 2022Article
- Incidence of Adult-Onset Epilepsy and the Contributory Role of Neurocysticercosis in a Five-Year, Population-Based, Prospective Study in Rural Ecuador.The American journal of tropical medicine and hygiene · 2021Article
- Collaborative scientific production of epilepsy in Latin America from 1989 to 2018: A bibliometric analysis.Heliyon · 2020Article
- Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.The Lancet. Neurology · 2019Article
- Mitochondrial damage in hippocampal neurons of rats with epileptic protein expression of Fas and caspase-3.Experimental and therapeutic medicine · 2018Article
- Non-attendance of vulnerable populations within epilepsy outpatient services in Ireland.Irish journal of medical science · 2018Article
- Effects of carbamazepine combined with vitamin B12 on levels of plasma homocysteine, hs-CRP and TNF-α in patients with epilepsy.Experimental and therapeutic medicine · 2018Article
- Article
- Diagnostic value and prognostic evaluation of dynamic video-electroencephalogram monitoring in children with epilepsy.Experimental and therapeutic medicine · 2017Article
- Identification of prevalent patients with epilepsy using administrative data: the Tuscany experience.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
objectivesTo determine the incidence and prevalence of treated epilepsy in an adult Medicaid population.
methodsWe performed a retrospective, dynamic cohort analysis using Ohio Medicaid claims data between 1992 and 2006. Individuals aged 18-64 years were identified as prevalent cases if they had ≥2 claims of epilepsy (ICD-9-CM: 345.xx) or ≥3 claims of convulsion (ICD-9-CM: 780.3 or 780.39) and ≥2 claims of antiepileptic drugs. Incident cases were required to have no epilepsy or convulsion claims for ≥5 years before epilepsy diagnosis. Subjects were determined as having preexisting disability and/or comorbid conditions, including brain tumor, depression, developmental disorders, migraine, schizophrenia, stroke, and traumatic brain injury, when at least one of these conditions occurred before epilepsy onset.
resultsThere were 9,056 prevalent cases of treated epilepsy in 1992-2006 and 1,608 incident cases in 1997-2006. The prevalence was 13.2/1,000 (95% confidence interval, 13.0-13.5/1,000). The incidence was 362/100,000 person-years (95% confidence interval, 344-379/100,000 person-years). The incidence and prevalence were significantly higher in men, in older people, in blacks, and in people with preexisting disability and/or comorbid conditions. The most common preexisting conditions in epilepsy subjects were depression, developmental disorders, and stroke, whereas people with brain tumor, traumatic brain injury, and stroke had the higher risk of developing epilepsy.
conclusionsThe Medicaid population has a high incidence and prevalence of epilepsy, in an order of magnitude greater than that reported in the US general population. This indigent population carries a disproportionate amount of the epilepsy burden and deserves more attention for its health care needs and support services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.